No Insurance Coverage for Osteoporosis Medication
Economy, Business And Markets

No Insurance Coverage for Osteoporosis Medication

Teriparatide (a prescription medicine used to treat osteoporosis) has been removed from the list of medicines covered by insurance for 45 days now, the head of Iranian Rheumatology Association, Ahmadreza Jamshidi, said. “Seven thousand patients have been suddenly denied insurance coverage of teriparatide, which is the only prescription medicine used to treat severe osteoporosis,” he said. “Teriparatide treatment’s duration for patients with osteoporosis is 18 to 24 months. Imagine a patient who has been on this drug for six months and now cannot afford to complete its expensive treatment,” he added. Without insurance coverage, patients have to pay ten times more, ILNA quoted a patient suffering from osteoporosis as saying.

Short URL : https://goo.gl/YZBTvv
  1. https://goo.gl/Sp9usk
  • https://goo.gl/Ct1wXE
  • https://goo.gl/8YDms3
  • https://goo.gl/gY1fWW
  • https://goo.gl/vtWdvX

You can also read ...

Italian investment companies remain active in Iran, despite...
Iranian Insurance Firms' Premium Income Exceeds $1.2b in H1 (Mar-Sep 2018)
Iran insurance industry earned 183 trillion rials ($1.28...
Iran, India Leading Global Ammonia Capacity Growth
Iran and India will continue to lead the global ammonia market...
Iran Auto Industry Hither and Thither
Over the past few days, Iran’s beleaguered auto industry has...
Iran-Russia Non-Oil Trade Sees Over 80 Percent Hike (September 2018)
Iran traded 956,662 tons of non-oil commodities worth close to...
US Sanctions Against Iran Ridicule Int'l Norms
Foreign Ministry Spokesman Bahram Qasemi on Wednesday...
First-Timers Constitute 20% of Tehran Homebuyers
First-time homebuyers have accounted for a 20% share of total...
Iran Slips 1 Spot in WEF's Global Competitiveness Index
The World Economic Forum’s “Global Competitiveness Report 2018...

Add new comment

Read our comment policy before posting your viewpoints